This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

DSM-Firmenich Toekomstige groei

We currently don't have sufficient analyst coverage to forecast growth and revenue for DSM-Firmenich.

20.5%

Groei van de winst

18.3%

Groei van de winst per aandeel

Chemicals winstgroei	52.5%
Inkomstengroei	11.1%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Good
Laatst bijgewerkt	16 May 2023

Geen updates

Winst- en omzetgroeiprognoses

BMV:DSM N - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2025	14,665	1,015	749	1,913	8
12/31/2024	13,934	687	847	1,913	9
12/31/2023	12,024	546	344	1,084	9
12/31/2022	8,390	454	314	965	N/A
9/30/2022	9,582	837	412	1,056	N/A
6/30/2022	9,802	1,082	510	1,147	N/A
3/31/2022	9,503	1,081	680	1,287	N/A
12/31/2021	7,269	820	850	1,427	N/A
9/30/2021	7,955	660	884	1,507	N/A
6/30/2021	7,558	493	906	1,489	N/A
3/31/2021	7,572	423	906	1,497	N/A
12/31/2020	8,106	448	868	1,494	N/A
9/30/2020	7,960	510	809	1,434	N/A
6/30/2020	8,034	557	810	1,462	N/A
3/31/2020	9,011	722	826	1,471	N/A
12/31/2019	7,998	675	744	1,385	N/A
9/30/2019	8,272	820	766	1,399	N/A
6/30/2019	8,502	794	747	1,395	N/A
3/31/2019	9,124	934	612	1,282	N/A
12/31/2018	9,267	1,069	698	1,391	N/A
9/30/2018	9,235	984	657	1,310	N/A
6/30/2018	9,106	2,082	550	1,170	N/A
3/31/2018	8,908	1,942	512	1,110	N/A
12/31/2017	8,632	1,761	441	996	N/A
9/30/2017	8,471	1,676	431	993	N/A
6/30/2017	8,333	738	470	1,028	N/A
3/31/2017	8,166	711	554	1,077	N/A
12/31/2016	7,920	645	523	1,018	N/A
9/30/2016	7,831	588	N/A	958	N/A
6/30/2016	7,778	274	N/A	914	N/A
3/31/2016	7,749	214	N/A	811	N/A
12/31/2015	7,722	174	N/A	696	N/A
9/30/2015	7,607	66	N/A	800	N/A
6/30/2015	7,456	114	N/A	820	N/A
3/31/2015	7,245	115	N/A	867	N/A
12/31/2014	7,051	123	N/A	808	N/A
9/30/2014	7,415	112	N/A	866	N/A
6/30/2014	7,834	138	N/A	885	N/A
3/31/2014	8,362	182	N/A	1,010	N/A
12/31/2013	8,858	252	N/A	998	N/A
9/30/2013	8,409	363	N/A	705	N/A
6/30/2013	8,500	335	N/A	638	N/A
3/31/2013	8,486	257	N/A	584	N/A
12/31/2012	8,588	280	N/A	730	N/A
9/30/2012	9,089	453	N/A	950	N/A
6/30/2012	9,107	543	N/A	1,020	N/A

Verdiensten versus spaarpercentage: DSM N's forecast earnings growth (20.5% per year) is above the savings rate (7.6%).

Winst versus markt: DSM N's earnings (20.5% per year) are forecast to grow faster than the MX market (9% per year).

Hoge groeiwinsten: DSM N's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: DSM N's revenue (11.1% per year) is forecast to grow faster than the MX market (5.7% per year).

Hoge groei-inkomsten: DSM N's revenue (11.1% per year) is forecast to grow slower than 20% per year.

Toekomstige ROE: Insufficient data to determine if DSM N's Return on Equity is forecast to be high in 3 years time